Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

440 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer

NCT01545947

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cedars Sinai Medical Center, Inflammatory Bowel Disease Center Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • NYU School of Medicine New York, United States
  • Cancer Center of the Carolinas Greenville, South Carolina, United States
View Trial Details
Completed

A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

NCT01478685

Conditions
Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +49 more
Locations
  • Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View all 13 locations
View Trial Details
Completed

Adjuvant Pazopanib in Stage I NSCLC

NCT00775307

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Annemasse - CH Ambilly, France
  • Béziers - CH Béziers, France
  • Bobigny - Hôpital Avicenne Bobigny, France
  • Bordeaux - Polyclinique Nord Bordeaux, France
View all 40 locations
View Trial Details
Completed

A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants

NCT01900652

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California - San Diego La Jolla, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States
  • University of California, Davis - Health Systems Sacramento, California, United States
View all 59 locations
View Trial Details
Completed

A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT01160744

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Scottsdale, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tucson, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Corona, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fountain Valley, California, United States
View all 53 locations
View Trial Details
Completed

Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)

NCT00153803

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Birmingham Hematology and Oncology Associates, LLC Birmingham, Alabama, United States
  • Oncology Specialties, P.C. Huntsville, Alabama, United States
  • Cooper Clinic Fort Smith, Arkansas, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
View all 65 locations
View Trial Details
Completed

Afatinib (BIBW 2992) in Advanced Non-Small Cell Lung Cancer Patients With EGFR Mutation

NCT01953913

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • 307 Hospital of PLA Beijing, China
  • Beijing Cancer Hospital Beijing, China
  • Chinese PLA General Hospital Beijing, China
  • Jilin Province Cancer Hospital Changchun, China
View all 33 locations
View Trial Details

Related conditions